Monoclonal for Dengue Shows Promise in Hospitalized Cases

(MedPage Today) -- An investigational monoclonal antibody targeting dengue virus (Dengue-mAb) safely reduced viral loads and infection symptoms, according to a placebo-controlled phase II trial in India.
Among 249 adults hospitalized with dengue...